97 related articles for article (PubMed ID: 7996381)
1. Plasma levels of peptide YY correlate with cisplatin-induced emesis in dogs.
Perry MR; Rhee J; Smith WL
J Pharm Pharmacol; 1994 Jul; 46(7):553-7. PubMed ID: 7996381
[TBL] [Abstract][Full Text] [Related]
2. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.
Castejon AM; Paez X; Hernandez L; Cubeddu LX
J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811
[TBL] [Abstract][Full Text] [Related]
3. Type A Trichothecene Diacetoxyscirpenol-Induced Emesis Corresponds to Secretion of Peptide YY and Serotonin in Mink.
Wu Q; Kuca K; Nepovimova E; Wu W
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32630472
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo.
Eglen RM; Lee CH; Smith WL; Johnson LG; Clark R; Whiting RL; Hegde SS
Br J Pharmacol; 1995 Feb; 114(4):860-6. PubMed ID: 7773547
[TBL] [Abstract][Full Text] [Related]
5. Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).
Wu W; Bates MA; Bursian SJ; Flannery B; Zhou HR; Link JE; Zhang H; Pestka JJ
Toxicol Sci; 2013 May; 133(1):186-95. PubMed ID: 23457120
[TBL] [Abstract][Full Text] [Related]
6. Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model.
Endo T; Hamaue N; Ihira E; Teramoto Y; Liu Y; Hirafuji M; Minami M
Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):55-68. PubMed ID: 14632314
[TBL] [Abstract][Full Text] [Related]
7. Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew).
Sam TS; Cheng JT; Johnston KD; Kan KK; Ngan MP; Rudd JA; Wai MK; Yeung JH
Eur J Pharmacol; 2003 Jul; 472(1-2):135-45. PubMed ID: 12860482
[TBL] [Abstract][Full Text] [Related]
8. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
Yoshida N; Omoya H; Ito T
J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
[TBL] [Abstract][Full Text] [Related]
9. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
[TBL] [Abstract][Full Text] [Related]
10. Repeated administration of the 5-HT3 receptor antagonist granisetron reduces the incidence of delayed cisplatin-induced emesis in the piglet.
Grélot L; Le Stunff H; Milano S; Blower PR; Romain D
J Pharmacol Exp Ther; 1996 Oct; 279(1):255-61. PubMed ID: 8859001
[TBL] [Abstract][Full Text] [Related]
11. The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis.
Milano S; Blower P; Romain D; Grélot L
J Pharmacol Exp Ther; 1995 Aug; 274(2):951-61. PubMed ID: 7636759
[TBL] [Abstract][Full Text] [Related]
12. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
Kenward H; Elliott J; Lee T; Pelligand L
BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
[TBL] [Abstract][Full Text] [Related]
13. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
14. Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. The Ondansetron and Granisetron Emesis Study Group.
Ruff P; Paska W; Goedhals L; Pouillart P; Rivière A; Vorobiof D; Bloch B; Jones A; Martin C; Brunet R
Oncology; 1994; 51(1):113-8. PubMed ID: 8265095
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy.
Fukui H; Yamamoto M
Eur J Pharmacol; 1999 May; 372(3):261-7. PubMed ID: 10395021
[TBL] [Abstract][Full Text] [Related]
16. Emesis to trichothecene deoxynivalenol and its congeners correspond to secretion of peptide YY and 5-HT.
Wei B; Xiao H; Xu B; Kuca K; Qin Z; Guo X; Wu W; Wu Q
Food Chem Toxicol; 2023 Aug; 178():113874. PubMed ID: 37286030
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of gastrointestinal abnormal motor activity induced by cisplatin in conscious dogs.
Ando H; Mochiki E; Ohno T; Yanai M; Toyomasu Y; Ogata K; Tabe Y; Aihara R; Nakabayashi T; Asao T; Kuwano H
World J Gastroenterol; 2014 Nov; 20(42):15691-702. PubMed ID: 25400453
[TBL] [Abstract][Full Text] [Related]
18. An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret.
Rudd JA; Naylor RJ
Br J Pharmacol; 1996 May; 118(2):209-14. PubMed ID: 8735616
[TBL] [Abstract][Full Text] [Related]
19. Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group.
Navari R; Gandara D; Hesketh P; Hall S; Mailliard J; Ritter H; Friedman C; Fitts D
J Clin Oncol; 1995 May; 13(5):1242-8. PubMed ID: 7738628
[TBL] [Abstract][Full Text] [Related]
20. 5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin.
Rudd JA; Ngan MP; Wai MK
Eur J Pharmacol; 1998 Jul; 352(2-3):143-9. PubMed ID: 9716348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
